Eris Lifesciences Ltd. has a share price target of Rs 1513, revenue growth forecast of 47.8%, and profit growth estimate of -6.9% for FY25, based on top 9 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature